Mitsuhiro. Ito, et.al., TIP30 deficiency increases susceptibility to tumorigenesis., Cancer research, 2003, 63

http://rdf.ncbi.nlm.nih.gov/pubmed/14695192

Mitsuhiro. Ito, et.al., TIP30 deficiency increases susceptibility to tumorigenesis., Cancer research, 2003, 63

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD41493
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD41493

allele

http://purl.org/net/cito/citesAsAuthority

• Htatip2<tm1Hx>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3026855

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased urinary bladder transitional cell carcinoma incidence_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0009551I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• increased uterus leiomyoma incidence_Htatip2<tm1Hx>/Htatip2<tm1Hx>
  http://metadb.riken.jp/0003570I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2tm1HxHtatip2tm1Hx
• increased thymoma incidence_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0014127I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• increased carcinoma incidence_Htatip2<tm1Hx>/Htatip2<tm1Hx>
  http://metadb.riken.jp/0002038I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2tm1HxHtatip2tm1Hx
• increased hemangiosarcoma incidence_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0003667I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• increased sarcoma incidence_Htatip2<tm1Hx>/Htatip2<tm1Hx>
  http://metadb.riken.jp/0002032I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2tm1HxHtatip2tm1Hx
• increased hepatocellular carcinoma incidence_Htatip2<tm1Hx>/Htatip2<tm1Hx>
  http://metadb.riken.jp/0003331I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2tm1HxHtatip2tm1Hx
• increased metastatic potential_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0001272I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• increased fibroblast proliferation_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0011703I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• abnormal mammary gland morphology_Htatip2<tm1Hx>/Htatip2<tm1Hx>
  http://metadb.riken.jp/0000627I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2tm1HxHtatip2tm1Hx
• increased tumor incidence_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0002020I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• increased malignant tumor incidence_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0002018I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• increased duodenum adenocarcinoma incidence_Htatip2<tm1Hx>/Htatip2<tm1Hx>
  http://metadb.riken.jp/0009311I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2tm1HxHtatip2tm1Hx
• increased ovary tumor incidence_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0008000I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• increased hepatocellular carcinoma incidence_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0003331I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• increased fibroblast proliferation_Htatip2<tm1Hx>/Htatip2<tm1Hx>
  http://metadb.riken.jp/0011703I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2tm1HxHtatip2tm1Hx
• increased tumor incidence_Htatip2<tm1Hx>/Htatip2<tm1Hx>
  http://metadb.riken.jp/0002020I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2tm1HxHtatip2tm1Hx
• increased neuroblastoma incidence_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0002039I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• increased carcinoma incidence_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0002038I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• abnormal cell physiology_Htatip2<tm1Hx>/Htatip2<tm1Hx>
  http://metadb.riken.jp/0005621I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2tm1HxHtatip2tm1Hx
• abnormal cell physiology_Htatip2<tm1Hx>/Htatip2<+>
  http://metadb.riken.jp/0005621I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2Htatip2tm1HxHtatip2
• increased malignant tumor incidence_Htatip2<tm1Hx>/Htatip2<tm1Hx>
  http://metadb.riken.jp/0002018I129P2OlaHsdC57BL6JHtatip2tm1HxHtatip2tm1HxHtatip2tm1Hx